Literature DB >> 10892862

Simulation of longitudinal threshold visual field data.

P G Spry1, A B Bates, C A Johnson, B C Chauhan.   

Abstract

PURPOSE: To describe and evaluate a computer model that simulates longitudinal visual field data.
METHODS: A computer model was designed using factors that influence thresholds of normal and glaucomatous visual fields. The simulation model was used to quantify the effects of fluctuation on the outcomes of pointwise linear regression by comparison with simulated gold standard data with no variability.
RESULTS: Serial sets of 10 stable and 10 progressive visual fields with different fluctuation levels were generated by simulation and were analyzed using pointwise linear regression. Regression outcome measures used were slopes of -1 dB/year or worse and slopes of -1 dB/year or worse that were also statistically significant. In stable visual fields, the number of locations with regression slopes worse than -1 dB/year increased with fluctuation and defect size and was inversely related to the number of fields. The number of locations with statistically significant slopes remained low and appeared unaffected by these variables. In progressive visual fields, analysis of a small number of visual field test results (<8) overestimated the number of locations with regression slopes worse than -1 dB/year and underestimated the number of locations with statistically significant slopes.
CONCLUSIONS: Computer simulation may be used to provide a gold standard outcome that permits evaluation of statistical tools for monitoring progressive glaucomatous visual field loss.

Entities:  

Mesh:

Year:  2000        PMID: 10892862

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

1.  Frequency of testing for detecting visual field progression.

Authors:  S K Gardiner; D P Crabb
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

2.  Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.

Authors:  Carlos Gustavo De Moraes; Shaban Demirel; Stuart K Gardiner; Jeffrey M Liebmann; George A Cioffi; Robert Ritch; Mae O Gordon; Michael A Kass
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-02       Impact factor: 4.799

3.  Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.

Authors:  John L Keltner; Chris A Johnson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2005-09

Review 4.  Functional assessment of glaucoma: Uncovering progression.

Authors:  Rongrong Hu; Lyne Racette; Kelly S Chen; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2020-04-26       Impact factor: 6.048

Review 5.  Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.

Authors:  C Gustavo De Moraes; Jeffrey M Liebmann; Leonard A Levin
Journal:  Prog Retin Eye Res       Date:  2016-10-20       Impact factor: 21.198

6.  Refinement of pointwise linear regression criteria for determining glaucoma progression.

Authors:  Colleen M Kummet; K D Zamba; Carrie K Doyle; Chris A Johnson; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-19       Impact factor: 4.799

7.  Baseline mean deviation and rates of visual field change in treated glaucoma patients.

Authors:  I Forchheimer; C G de Moraes; C C Teng; F Folgar; C Tello; R Ritch; J M Liebmann
Journal:  Eye (Lond)       Date:  2011-03-11       Impact factor: 3.775

8.  A two-stage neural spiking model of visual contrast detection in perimetry.

Authors:  S K Gardiner; W H Swanson; S Demirel; A M McKendrick; A Turpin; C A Johnson
Journal:  Vision Res       Date:  2008-07-21       Impact factor: 1.886

9.  Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure.

Authors:  T Aung; F T S Oen; H-T Wong; Y-H Chan; B-K Khoo; Y-P Liu; C-L Ho; J See; L H Thean; A C Viswanathan; S K L Seah; P T K Chew
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

10.  Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma.

Authors:  Diana Salazar; Esteban Morales; Alessandro Rabiolo; Vicente Capistrano; Mark Lin; Abdelmonem A Afifi; Fei Yu; Kouros Nouri-Mahdavi; Joseph Caprioli
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.